TCGA stomach adenocarcinoma data (Nature 2014, 173 cases of intestinal type and 65 cases of diffuse type) also confirmed that the expression levels of RNASET2 mRNA were lower in diffuse type GAC than that in intestinal type GAC (p = 0.0048; Figure 2F). This evidence concerns the gene RNASET2 and gastric adenocarcinoma.